University of Houston: Discovery of Drug Candidate That Neutralizes SARS-CoV-2 Could Reduce Length of Infection Upon Exposure
March 29, 2023
March 29, 2023
HOUSTON, Texas, March 29 (TNSres) -- The University of Houston issued the following news release:
* * *
May Be Helpful for High-Risk and Immunocompromised Individuals
* * *
The discovery of a small molecule in the research lab of Bradley McConnell, professor of pharmacology at the University of Houston College of Pharmacy, may well be the genesis of new medication which could shorten the course of the SARS-CoV-2 virus. Unlike Pfizer's antiviral . . .
* * *
May Be Helpful for High-Risk and Immunocompromised Individuals
* * *
The discovery of a small molecule in the research lab of Bradley McConnell, professor of pharmacology at the University of Houston College of Pharmacy, may well be the genesis of new medication which could shorten the course of the SARS-CoV-2 virus. Unlike Pfizer's antiviral . . .